Michael S Saag

8.1k total citations · 1 hit paper
24 papers, 3.8k citations indexed

About

Michael S Saag is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Michael S Saag has authored 24 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 12 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Michael S Saag's work include HIV/AIDS drug development and treatment (14 papers), HIV/AIDS Research and Interventions (13 papers) and HIV Research and Treatment (12 papers). Michael S Saag is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV/AIDS Research and Interventions (13 papers) and HIV Research and Treatment (12 papers). Michael S Saag collaborates with scholars based in United States, United Kingdom and Canada. Michael S Saag's co-authors include George M. Shaw, Beatrice H. Hahn, Sajal K. Ghosh, Xiping Wei, Maria E. Taylor, Sebastian Bonhoeffer, Jeffrey D. Lifson, Victoria A. Johnson, Martin A. Nowak and Paul Deutsch and has published in prestigious journals such as Nature, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael S Saag

22 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral dynamics in human immunodeficiency virus type 1 infection

1995 2.6k citations Xiping Wei, Sajal K. Ghosh et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael S Saag United States	13	2.6k	2.5k	1.1k	780	345	24	3.8k
Eric Sandström Sweden	35	1.7k 0.6×	1.6k 0.7×	1.2k 1.0×	917 1.2×	612 1.8×	169	3.9k
Pontiano Kaleebu Uganda	36	2.5k 1.0×	3.0k 1.2×	1.2k 1.1×	742 1.0×	534 1.5×	266	4.9k
Charles B. Hicks United States	36	2.1k 0.8×	2.3k 0.9×	886 0.8×	547 0.7×	341 1.0×	115	3.8k
Phyllis J. Kanki United States	40	3.6k 1.4×	3.5k 1.4×	1.7k 1.5×	1.2k 1.6×	480 1.4×	162	5.9k
Sergio Lo Caputo Italy	30	1.7k 0.7×	1.7k 0.7×	860 0.8×	896 1.1×	315 0.9×	147	3.2k
James O. Kahn United States	36	3.5k 1.4×	3.6k 1.4×	1.7k 1.5×	1.3k 1.7×	484 1.4×	70	5.8k
Maria E. Taylor United States	11	2.7k 1.1×	1.9k 0.8×	821 0.7×	1.0k 1.3×	386 1.1×	14	3.8k
Chanson J. Brumme Canada	31	2.6k 1.0×	2.0k 0.8×	685 0.6×	1.2k 1.5×	524 1.5×	112	3.5k
Martin Markowitz United States	33	3.0k 1.2×	2.7k 1.1×	955 0.8×	1.2k 1.6×	535 1.6×	60	4.2k
Vladimir Novitsky United States	29	2.4k 0.9×	1.9k 0.8×	685 0.6×	721 0.9×	676 2.0×	95	3.1k

Countries citing papers authored by Michael S Saag

Since Specialization

Citations

This map shows the geographic impact of Michael S Saag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S Saag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S Saag more than expected).

Fields of papers citing papers by Michael S Saag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S Saag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S Saag. The network helps show where Michael S Saag may publish in the future.

Co-authorship network of co-authors of Michael S Saag

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S Saag. A scholar is included among the top collaborators of Michael S Saag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S Saag. Michael S Saag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beydoun, Nour, Matthew S. Durstenfeld, Bridget M. Whitney, et al.. (2025). Multicenter study of heart failure phenotypes and physician-adjudicated causes in people with HIV. AIDS. 39(9). 1246–1253.

Eaton, Ellen, Ashutosh Tamhane, Michael S Saag, Michael J. Mugavero, & Meredith L. Kilgore. (2016). Cost considerations in the current antiretroviral era. AIDS. 30(14). 2215–2219. 5 indexed citations

May, Margaret, Amy C. Justice, Kate Birnie, et al.. (2015). Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(3). 348–354. 38 indexed citations

Post, Frank A., Michael S Saag, Michael T. Yin, et al.. (2015). P99 Renal and bone safety of tenofovir alafenamide vs tenofovir disoproxil fumarate. Sexually Transmitted Infections. 91(Suppl 1). A48.3–A49. 5 indexed citations

Gilbert, David N., Robert C. Moellering, George M. Eliopoulos, et al.. (2013). Przewodnik terapii przeciwdrobnoustrojowej Sanforda 2013. 1 indexed citations

Stringer, Jeffrey S. A., Lloyd Mulenga, Jens Levy, et al.. (2012). Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study. International Journal of Epidemiology. 41(2). 448–459. 9 indexed citations

May, Margaret, Robert S. Hogg, Amy C. Justice, et al.. (2012). Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. International Journal of Epidemiology. 41(6). 1807–1820. 19 indexed citations

Hogg, Robert S., Margaret May, Sophie Abgrall, et al.. (2011). The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine. 13(2). 89–97. 44 indexed citations

McKinnell, James A., Hui‐Yi Lin, James H. Willig, et al.. (2009). Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study. AIDS. 23(12). 1539–1546. 11 indexed citations

10.

Ulett, Kimberly B., James H. Willig, Hui‐Yi Lin, et al.. (2008). The Therapeutic Implications of Timely Linkage and Early Retention in HIV Care. AIDS Patient Care and STDs. 23(1). 41–49. 335 indexed citations

11.

Tan, Ruimin, Andrew O. Westfall, James H. Willig, et al.. (2008). Clinical Outcome of HIV-Infected Antiretroviral-Naive Patients With Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(5). 553–558. 89 indexed citations

12.

Sterne, Jonathan A C, Sophie Abgrall, François Dabis, et al.. (2008). Prognostic Importance of Anaemia in HIV Type-1-Infected Patients Starting Antiretroviral Therapy: Collaborative Analysis of Prospective Cohort Studies. Antiviral Therapy. 13(8). 959–967. 66 indexed citations

13.

Effros, Rita B., Steven N. Austad, Helen M. Blau, et al.. (2008). The Biological Sciences Section Program at the 60th Annual Meeting of The Gerontological Society of America. The Journals of Gerontology Series A. 63(4). 331–337. 2 indexed citations

14.

Jackson, David A., Andrew O. Westfall, Jeroan J. Allison, et al.. (2008). Clinical Inertia in the Management of Low‐Density Lipoprotein Abnormalities in an HIV Clinic. Clinical Infectious Diseases. 46(8). 1315–1318. 12 indexed citations

15.

Westfall, Andrew O., Jeroan J. Allison, Nicholas Van Wagoner, et al.. (2007). Nucleoside Reverse-Transcriptase Inhibitor Dosing Errors in an Outpatient HIV Clinic in the Electronic Medical Record Era. Clinical Infectious Diseases. 45(5). 658–661. 18 indexed citations

16.

Saravolatz, Louis D. & Michael S Saag. (2005). Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus. Clinical Infectious Diseases. 42(1). 126–131. 62 indexed citations

17.

Hockett, Richard D., et al.. (2000). Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR. Journal of Virological Methods. 87(1-2). 1–12. 8 indexed citations

18.

Pan, George, et al.. (1998). Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS. Immunopharmacology. 40(2). 91–103. 21 indexed citations

19.

Wei, Xiping, Sajal K. Ghosh, Maria E. Taylor, et al.. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373(6510). 117–122. 2584 indexed citations breakdown →

20.

Ghosh, Sajal K., Patricia N. Fultz, Michael S Saag, et al.. (1993). A Molecular Clone of HIV-1 Tropic and Cytopathic for Human and Chimpanzee Lymphocytes. Virology. 194(2). 858–864. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact